
The Prostate Cancer Diagnostics Market has demonstrated remarkable resilience and innovation in the face of evolving healthcare challenges, recording a market valuation of USD 8.57 billion in 2023. With advancements in diagnostic technologies and increasing global awareness surrounding prostate cancer, this market is poised to witness substantial growth. As governments, healthcare providers, and..